Findair is a med-tech startup based in Krakow, Poland, that focuses on smart inhaler technology to enable remote asthma care. Founded in 2016, the company specializes in medication monitoring through innovative solutions in Telemedicine, Remote Patient Monitoring, and clinical trial support for asthma and COPD. Their products, including FindAir ONE and Smarthaler, utilize connected medical hardware, web software, and AI to enhance treatment outcomes and patient safety. With a recent $1.70M Seed Round investment on 21 June 2023, from 4growth VC and NCBR Investment Fund ASI S.A., Findair is well-positioned to advance healthcare technologies and improve the quality of life for patients globally.
General Information
BounceWatch is an independent company data service, not affiliated with Findair. To contact Findair, visit findair.eu.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Poland Market
Enterprise Software
About Findair
Taxonomy: Smart Inhalers, Med-tech, Telemedicine, Remote Patient Monitoring, Clinical Trials, Asthma, COPD, Digital Health, Drug Delivery, Medical Device, Respiratory, Telehealth
Funding Rounds & Investors (3)
View AllFindair Alternatives & Competitors
View All AlternativesDigital Lung Acoustics for Better Insight | Cough, Wheeze, Crackles
StethoMe® A smart way of monitoring kid’s asthma
Using sensor tech and data analytics to manage your airways condition
FAQ About Findair
Source: BounceWatch company record for Findair, https://bouncewatch.com/company/findair, updated 3 March 2025. When citing, please name BounceWatch and link this page.